Patients with heightened TP53 expression experienced significantly shorter overall survival and notably unfavorable prognoses in cancers including BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, HNSC, KICH, KIRC, LIHC, LUAD, LUSC, UCEC and a few others, as mentioned above (refer to Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12, Figure 13 and Figure 14). Here, TP53 is linked to cancer.